Inflammatory activity and vitamin D levels in an MS population treated with rituximab

BACKGROUND: Most multiple sclerosis patients on disease-modifying treatment at Umeå University Hospital are treated with rituximab and the prevalence of vitamin D supplementation has increased over time. Follow-up studies of these off-label treatments are needed. OBJECTIVE: To study inflammatory act...

Descripción completa

Detalles Bibliográficos
Autores principales: Linden, Johan, Granåsen, Gabriel, Salzer, Jonatan, Svenningsson, Anders, Sundström, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378455/
https://www.ncbi.nlm.nih.gov/pubmed/30800416
http://dx.doi.org/10.1177/2055217319826598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378455/
https://www.ncbi.nlm.nih.gov/pubmed/30800416
http://dx.doi.org/10.1177/2055217319826598

Ejemplares similares